Component: (Network and Table)
Network
00400 - Statement - STATEMENTS OF CASH FLOWS
(http://www.celldextherapeutics.com/role/StatementStatementsOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000744218 (http://www.sec.gov/CIK)
STATEMENTS OF CASH FLOWSPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
STATEMENTS OF CASH FLOWS
 
 
 
Cash Flows From Operating Activities:
 
 
 
Net Loss
(128,530,000) 
(127,197,000) 
(118,080,000) 
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:
 
 
 
Depreciation and Amortization
3,095,000  
2,998,000  
2,388,000  
Amortization of Intangible Assets
997,000  
1,013,000  
1,013,000  
Amortization and Premium of Marketable Securities, Net
926,000  
350,000  
95,000  
Realized Gain on Sales and Maturities of Marketable Securities
  
(11,000) 
Loss on Sale or Disposal of Assets
81,000  
 
6,000  
Stock-Based Compensation Expense
15,317,000  
12,774,000  
6,852,000  
Non-Cash Expense
1,638,000  
288,000  
72,000  
Changes in Operating Assets and Liabilities:
 
 
 
Accounts and Other Receivables
(814,000) 
(543,000) 
62,000  
Prepaid and Other Current Assets
1,320,000  
(653,000) 
(2,026,000) 
Other Assets
(89,000) 
6,000  
65,000  
Accounts Payable and Accrued Expenses
(4,970,000) 
4,875,000  
1,450,000  
Other Liabilities
(2,007,000) 
7,202,000  
6,577,000  
Net Cash Used in Operating Activities
(113,036,000) 
 
(98,887,000) 
 
(101,537,000) 
 
Cash Flows From Investing Activities:
 
 
 
Sales and Maturities of Marketable Securities
242,792,000  
161,090,000  
109,232,000  
Purchases of Marketable Securities
(173,925,000) 
(206,405,000) 
(148,314,000) 
Investment in Other
(1,801,000) 
  
Cash Acquired in Kolltan Acquisition, net
4,592,000  
  
Acquisition of Property and Equipment
(2,751,000) 
(4,876,000) 
(1,929,000) 
Net Cash Provided by (Used in) Investing Activities
68,907,000  
 
(50,191,000) 
 
(41,011,000) 
 
Cash Flows From Financing Activities:
 
 
 
Net Proceeds from Stock Issuances
13,946,000  
188,840,000  
 
Proceeds from Issuance of Stock from Employee Benefit Plans
536,000  
4,311,000  
1,171,000  
Net Cash Provided by Financing Activities
14,482,000  
 
193,151,000  
 
1,171,000  
 
Effect of Exchange Rate Changes on Cash and Cash Equivalents
 
15,000  
(5,000) 
Net (Decrease) Increase in Cash and Cash Equivalents
(29,647,000) 
 
44,088,000  
 
(141,382,000) 
 
Cash and Cash Equivalents at Beginning of Period
72,108,000  
28,020,000  
169,402,000  
Cash and Cash Equivalents at End of Period
42,461,000  
 
72,108,000  
 
28,020,000  
 
Non-cash Investing Activities
 
 
 
Accrued construction in progress
159,000  
75,000  
1,027,000  
Non-cash Supplemental Disclosure
 
 
 
Shares issued to former Kolltan executive for settlement of severance
426,000  
  
Shares issued in connection with Kolltan Acquisition
73,397,000